Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025)
Tandem Diabetes Care posted quarterly Short term Debt of $40.7 million for Q1 2025, little changed on a QoQ basis from $40.7 million in Q4 2024.
Tandem Diabetes Care (TNDM) has 2 years of Short term Debt data on file, last reported at $40.7 million in Q1 2025.
- For the quarter ending Q1 2025, Short term Debt changed N/A year-over-year to $40.7 million; the trailing twelve-month figure through Mar 2025 stood at $40.7 million (changed N/A YoY), and the FY2024 full-year result was $40.7 million, changed N/A from the prior year.
- Short term Debt for Q1 2025 stood at $40.7 million, roughly flat from $40.7 million in the prior quarter.
- Across five years, Short term Debt topped out at $40.7 million in Q1 2025 and bottomed at $40.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 40.74 Mn |
| Dec 31, 2024 | 40.67 Mn |
| Sep 30, 2024 | 40.61 Mn |
| Jun 30, 2024 | 40.54 Mn |